Wanglong Deng

L2hgdh Deficiency Accumulates l-2-Hydroxyglutarate with Progressive Leukoencephalopathy and Neurodegeneration

Y. Xiong, Pengyuan Yang, P. Liu, 2017, Molecular and Cellular Biology.

General mechanism of JQ1 in inhibiting various types of cancer

Chengde Wang, Guojuan Jiang, Wanglong Deng, 2020, Molecular medicine reports.

D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth

Y. Xiong, K. Guan, Hui Yang, 2015, Oncotarget.

Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial

Liyong Pu, Xiangcheng Li, Si Li, 2022, Journal for ImmunoTherapy of Cancer.

Regulatory mechanism and functional analysis of S100A9 in acute promyelocytic leukemia cells

H. Fan, Haiwei Wang, Ji Zhang, 2017, Frontiers of Medicine.

BRD4 interacts with PML/RARα in acute promyelocytic leukemia

H. Fan, Haiwei Wang, Ji Zhang, 2018, Frontiers of Medicine.

Activation of G0S2 is coordinated by recruitment of PML/RARα and C/EBPɛ to its promoter during ATRA‐induced APL differentiation

Jiang Zhu, Ji Zhang, Wanglong Deng, 2017, Journal of leukocyte biology.